BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1661 related articles for article (PubMed ID: 31016351)

  • 1. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
    Leslie WD; Martineau P; Bryanton M; Lix LM
    Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-energy distal radius fractures in middle-aged and elderly men and women--the burden of osteoporosis and fracture risk : A study of 1794 consecutive patients.
    Øyen J; Gjesdal CG; Brudvik C; Hove LM; Apalset EM; Gulseth HC; Haugeberg G
    Osteoporos Int; 2010 Jul; 21(7):1257-67. PubMed ID: 19813045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D.
    Hara T; Hijikata Y; Matsubara Y; Watanabe N
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013424. PubMed ID: 34231877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of hip and other osteoporotic fractures from hip geometry in a large clinical cohort.
    Leslie WD; Pahlavan PS; Tsang JF; Lix LM;
    Osteoporos Int; 2009 Oct; 20(10):1767-74. PubMed ID: 19238304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with bisphosphonate treatment failure in postmenopausal women with primary osteoporosis.
    Cairoli E; Eller-Vainicher C; Ulivieri FM; Zhukouskaya VV; Palmieri S; Morelli V; Beck-Peccoz P; Chiodini I
    Osteoporos Int; 2014 Apr; 25(4):1401-10. PubMed ID: 24510095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is lower income associated with an increased likelihood of qualification for treatment for osteoporosis in Canadian women?
    Brennan SL; Leslie WD; Lix LM
    Osteoporos Int; 2014 Jan; 25(1):273-9. PubMed ID: 23907573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FRAX provides robust fracture prediction regardless of socioeconomic status.
    Brennan SL; Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
    Osteoporos Int; 2014 Jan; 25(1):61-9. PubMed ID: 24190425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
    Tamaki J; Iki M; Kadowaki E; Sato Y; Chiba Y; Akiba T; Matsumoto T; Nishino H; Kagamimori S; Kagawa Y; Yoneshima H;
    Osteoporos Int; 2013 Mar; 24(3):887-97. PubMed ID: 22885773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases in hip and spine bone mineral density are predictive for vertebral antifracture efficacy with ibandronate.
    Miller PD; Delmas PD; Huss H; Patel KM; Schimmer RC; Adami S; Recker RR
    Calcif Tissue Int; 2010 Oct; 87(4):305-13. PubMed ID: 20737140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial.
    Eastell R; Lang T; Boonen S; Cummings S; Delmas PD; Cauley JA; Horowitz Z; Kerzberg E; Bianchi G; Kendler D; Leung P; Man Z; Mesenbrink P; Eriksen EF; Black DM;
    Osteoporos Int; 2010 Jul; 21(7):1277-85. PubMed ID: 19802508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.
    Meunier PJ; Roux C; Ortolani S; Diaz-Curiel M; Compston J; Marquis P; Cormier C; Isaia G; Badurski J; Wark JD; Collette J; Reginster JY
    Osteoporos Int; 2009 Oct; 20(10):1663-73. PubMed ID: 19153678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FRAX Adjustment by Trabecular Bone Score with or Without Bone Mineral Density: The Manitoba BMD Registry.
    Leslie WD; Binkley N; McCloskey EV; Johansson H; Harvey NC; Lorentzon M; Kanis JA; Hans D
    J Clin Densitom; 2023; 26(3):101378. PubMed ID: 37137791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is bone microarchitecture status of the lumbar spine assessed by TBS related to femoral neck fracture? A Spanish case-control study.
    Del Rio LM; Winzenrieth R; Cormier C; Di Gregorio S
    Osteoporos Int; 2013 Mar; 24(3):991-8. PubMed ID: 22581295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hip structural geometry and incidence of hip fracture in postmenopausal women: what does it add to conventional bone mineral density?
    LaCroix AZ; Beck TJ; Cauley JA; Lewis CE; Bassford T; Jackson R; Wu G; Chen Z
    Osteoporos Int; 2010 Jun; 21(6):919-29. PubMed ID: 19756830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: the Manitoba study.
    Hans D; Goertzen AL; Krieg MA; Leslie WD
    J Bone Miner Res; 2011 Nov; 26(11):2762-9. PubMed ID: 21887701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fracture risk assessment without bone density measurement in routine clinical practice.
    Leslie WD; Morin S; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA;
    Osteoporos Int; 2012 Jan; 23(1):75-85. PubMed ID: 21850546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discriminatory capacity of BMD measurements by DXA and dual X-ray and laser (DXL) at the calcaneus including clinical risk factors for detecting patients with vertebral fractures.
    Muschitz C; Dimai HP; Kocijan R; Kaider A; Zendeli A; Kühne F; Trubrich A; Lung S; Waneck R; Resch H
    Osteoporos Int; 2013 Aug; 24(8):2181-90. PubMed ID: 23344258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial.
    Binkley N; Bone H; Gilligan JP; Krause DS
    Osteoporos Int; 2014 Nov; 25(11):2649-56. PubMed ID: 25027109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Discordant Hip Bone Density on Incident Fracture Risk: A Registry-Based Cohort Study.
    Leslie WD; Morin SN; Lix LM; McCloskey EV; Johansson H; Harvey NC; Kanis JA
    J Bone Miner Res; 2022 Oct; 37(10):2018-2024. PubMed ID: 36069122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.